Loading compound...

Small molecule research compound

ENDOXIFEN is a small molecule currently being studied in clinical research. It is being investigated for its potential use in treating bipolar I disorder and various types of breast cancer, including triple-negative breast cancer and breast carcinoma.

Used for
Bipolar I disorderAngiosarcomaTriple-negative breast cancerBreast cancerBreast carcinomaBreast ductal carcinoma in situNeoplasms
Conditions
Bipolar I disorderAngiosarcomaTriple-negative breast cancerBreast cancerBreast carcinomaBreast ductal carcinoma in situNeoplasm
Class
Small moleculeSmall molecule research compound

How to take

ENDOXIFEN is currently in clinical development phases and is not an FDA-approved medication for any indication listed above. Information is based on research data and clinical trial phases (Max Phase 1.0-3.0).

Talk to your doctor

Questions to ask

  • ·Is ENDOXIFEN part of any clinical trials I might qualify for?
  • ·How does ENDOXIFEN differ from my current cancer or bipolar medications?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.